Noah Medical develops medical robotics for endoluminal procedures, with a focus on navigated robotic bronchoscopy. Its first commercial product, the Galaxy System, integrates TiLT+ technology with tomosynthesis and augmented fluoroscopy, a single-use bronchoscope, and a compact footprint to improve procedural workflow in the lung biopsy market. The company positions the Galaxy System as an actionable clinical solution for interventional pulmonologists and has received positive feedback from clinicians who tested the platform. Noah Medical recently secured FDA clearance for commercial use in the United States and has initiated first-in-human trials at Macquarie University Hospital in Sydney, Australia. Led by founder and CEO Jian Zhang, PhD, the company is scaling commercial deployment of the Galaxy System to meet clinical demand. The Series B financing announced will support those commercialization and demand-driven scale-up efforts.

Total raised

$150M

Funding rounds

1

Latest round

Series B

Latest activity

Apr 2023